Hammersmith Medicines Research Limited

Active02779946 Private limited company

Incorporated: 15 January 1993 (33 years)
Industry: Other research and experimental development on natural sciences and engineering (72190)
Directors: Teena Joy Pisarev
Graham Keith Wood
Owned by: NN Bidco Pty Ltd (Acn 623 536 247)
Accounts type: Full
Region: Greater London
Address: 44 Cumberland Avenue
London
NW10 7EW

Filing status

Accounts due: 30 September 2027
Last accounts: 31 December 2025
Conf. stmt due: 29 January 2027
Last conf. stmt: 15 January 2026

Officers 2 active

Officer details are public data from the Companies House register.

Pisarev, Teena Joy

Director · Appointed 1 August 2025

Australian

Born September 1974 (52)

Wood, Graham Keith

Director · Appointed 1 August 2025

Canadian

Born May 1972 (54)

Officer history (6 former)

1 August 2025

Resigned Warrington, Steven John, Dr as Director

1 August 2025

Appointed Wood, Graham Keith as Director

1 August 2025

Resigned Boyce, Malcolm James, Dr as Director

1 August 2025

Appointed Pisarev, Teena Joy as Director

31 January 2025

Resigned O'Brien, Charles Kevin as Secretary

18 October 2013

Resigned Smith, Russell, Professor as Director

7 August 2012

Appointed Smith, Russell, Professor as Director

26 January 1996

Appointed Warrington, Steven John, Dr as Director

15 January 1995

Appointed O'Brien, Charles Kevin as Secretary

15 January 1995

Resigned Appleton Secretaries Limited as Corporate Nominee Secretary

18 January 1993

Appointed Boyce, Malcolm James, Dr as Director

18 January 1993

Resigned Appleton Directors Limited as Corporate Nominee Director

15 January 1993

Appointed Appleton Directors Limited as Corporate Nominee Director

15 January 1993

Appointed Appleton Secretaries Limited as Corporate Nominee Secretary

Ownership 1 active

People and entities with significant control, from the Companies House PSC register

NN Bidco Pty Ltd (Acn 623 536 247)

Corporate entity · Notified 1 August 2025

Owns 75–100% of shares

Holds 75–100% of voting rights

Right to appoint and remove directors

Proprietary Limited Company

Reg. no. Acn 623 536 247

Former controllers (1)

1 August 2025

Ceased Malcolm James Boyce — Owns 75–100% of shares

Financials

Figures from 2025 accounts. Newer accounts, made up to 31 December 2025, are filed but not read yet. See them on Companies House

Net Assets: £16,196,502
Cash: £2,344,753
Turnover: £24,671,858
Profit Before Tax: (£2,122,627)
Employees: 285

Debt Ratio: 16%
Current Ratio: 5.7x
Profit Margin: -9%
Return on Equity: -7%

Trend

Net Assets

Balance sheet detail

	2025	2024	2023	2022
Fixed Assets	£4,789,803	£11,282,288	£11,645,673	£11,897,776
Current Assets	£14,523,933	£17,039,078	£17,210,990	£18,080,281
Debtors		£11,955,284	£14,868,097	£12,755,430
Cash	£2,344,753	£3,714,410	£1,867,325	£4,804,980
Creditors (< 1 year)	£2,554,473	£2,748,548	£2,421,953	£1,767,819
Net Current Assets	£11,969,460	£14,290,530	£14,789,037	£16,312,462
Net Assets	£16,196,502	£23,665,179	£24,394,800	£25,726,238
Shareholder Funds	£16,196,502	£23,665,179	£24,394,800	£25,726,238

Turnover	£24,671,858
Cost of Sales	£16,224,113
Gross Profit	£8,447,745
Admin Expenses	£14,474,748
Staff Costs	£20,134,650
Operating Profit	(£2,276,243)
Profit Before Tax	(£2,122,627)
Tax	(£1,031,578)
Profit for Period	(£1,091,049)

Filings

Recent filings only. See the full history on Companies House

Date	Description	Made Up To	Pages	PDF
18 August 2026	Statement of company's objects
18 August 2026	Memorandum and Articles of Association
18 August 2026	Resolutions
13 July 2026	Statement of company's objects
13 July 2026	Previous accounting period shortened